Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lyon
Clinical trial register · France

Clinical Trials in Lyon, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 42 Lille 40 Lyon 35 Marseille 34 Montpellier 32
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Hospices Civils de Lyon187 AstraZeneca60 Centre Leon Berard51 GCS Ramsay Santé pour l'Enseignement et la Recherche36 Hoffmann-La Roche35 Clear sponsor filter
Site location
Paris42 Lille40 Lyon35 Marseille34 Montpellier32
All 69 locations
Target enrolment
to

Trials with a site in Lyon

35 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Grenoble, Lyon, Nice, Rennes, Toulouse
2026-05-21
Recruiting
Hoffmann-La Roche
Phase 2
80
Lille, Lyon, Marseille, Montpellier, Toulouse
2026-04-07
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Lyon, Marseille, Nice, Paris, Tours
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 2
100
Bordeaux, Villejuif, Lyon, Marseille
2026-03-11
Recruiting
Hoffmann-La Roche
Phase 3
250
Nantes, Lyon, Montauban, Paris, Poitiers, Strasbourg
2025-11-27
Recruiting
Hoffmann-La Roche
Phase 3
600
Angers, Bobigny, Bron, Caen, Lyon, Montpellier, Nice, Paris
2025-10-24
Active, closed
Hoffmann-La Roche
Phase 4
274
Bordeaux, Lyon, Paris, Saint-Cyr-sur-Loire, Saint-Jean
2025-03-14
Active, closed
Hoffmann-La Roche
Phase 3
338
Brest, Bron, Lille, Lyon, Montpellier, Nice, Paris, Pessac
2024-09-23
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
Hoffmann-La Roche
Phase 3
1,800
Amiens, Clichy, Dijon, Limoges, Lyon, Montpellier, Nice, Paris
2024-05-24
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
Hoffmann-La Roche
Phase 3
1,350
Amiens, Angers, Bordeaux, Clichy, Lille, Limoges, Lyon, Montpellier
2024-03-13
Active, closed
Hoffmann-La Roche
Phase 3
1,050
Angers, Avignon, Besançon, Caen, Clermont-Ferrand, La Rochelle, Lille, Lyon
2023-12-11
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Lille, Lyon, Marseille, Montpellier, Nantes, Pessac, Rennes, Rouen
2023-09-18
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Amiens, Lyon, Marseille, Nice, Pessac, Strasbourg
2023-06-28
Recruiting
Hoffmann-La Roche
Phase 3
420
Avignon, Bayonne, Bordeaux, Lyon, Montpellier, Rennes, Toulouse
2023-06-07
Recruiting
Hoffmann-La Roche
Phase 3
100
Marseille, Bordeaux, Caen, Dijon, Lyon, Montpellier, Nantes, Nîmes
2023-06-01
Active, closed
Hoffmann-La Roche
Phase 2
199
Avignon, Besançon, Bordeaux, Caen, Lyon, Villejuif
2023-04-21
Active, closed
Hoffmann-La Roche
Phase 2
204
Lyon, Villejuif
2023-04-13
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Strasbourg, Marseille, Dijon, Bordeaux, Nantes, Saint-Étienne-de-Montluc, Lyon, Rouen
2022-11-21
Active, closed
Hoffmann-La Roche
Phase 3
68
Caen, Lyon, Marseille
2022-11-01
Active, closed
Hoffmann-La Roche
Phase 3
922
Avignon, Bayonne, Besançon, Bordeaux, Grenoble, La Roche-sur-Yon, Lyon, Paris
2022-07-18
Active, closed
Hoffmann-La Roche
Phase 2
176
Besançon, Caen, Lyon, Paris, Rennes, Saint-Herblain, Toulouse, Villejuif
2021-10-07
Active, closed
Hoffmann-La Roche
Phase 3
217
Bordeaux, Lille, Lyon, Marseille, Rennes, Toulouse, Vantoux
2021-09-30
Active, closed
Hoffmann-La Roche
Phase 1/2
42
Lyon, Marseille, Paris
2021-09-14
Active, closed
Hoffmann-La Roche
Phase 3
451
Bordeaux, Lyon, Marseille, Paris
2021-07-14
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Avignon, Besançon, Bordeaux, Brest, Caen, Creil, Lyon, Nîmes
2021-05-04
Active, closed
Hoffmann-La Roche
Phase 3
761
Angers, Avignon, Bordeaux, Clermont-Ferrand, Lyon, Nancy, Paris, Suresnes
2021-05-03
Active, closed
Hoffmann-La Roche
Phase 2
920
Bordeaux, Lille, Lyon, Marseille, Toulouse, Villejuif
2021-01-18
Active, closed
Hoffmann-La Roche
Phase 1/2
210
Toulouse, Dijon, Lille, Lyon, Marseille, Saint-Herblain, Villejuif
2020-09-03
Active, closed
Hoffmann-La Roche
Phase 2/3
325
Clermont-Ferrand, Dijon, Lille, Lyon, Toulouse
2020-01-29
Recruiting
Hoffmann-La Roche
Phase 3
1,000
Bordeaux, Lyon, Marseille, Paris
2018-09-20
Recruiting
Hoffmann-La Roche
Phase 1/2
1,132
Lyon, Montpellier, Toulouse, Villejuif
2018-03-30
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
Bordeaux, Caen, Lille, Lyon, Nîmes, Nouilly, Paris, Poitiers
2017-09-22
Active, closed
Hoffmann-La Roche
Phase 3
382
Besançon, Grenoble, Lyon, Marseille, Nantes, Nice, Paris, Pierre-Bénite
2017-09-20
Active, closed
Hoffmann-La Roche
Phase 1/2
69
Lyon, Marseille
2016-05-03
Active, closed
Hoffmann-La Roche
Phase 2
534
Angers, Bordeaux, Lyon, Marseille, Montpellier, Paris, Toulouse, Villejuif
2015-11-19
Rows per page Showing 1–35 of 35
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 October 2026. https://priyalifescience.com/clinical-trials-france/city/lyon

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 35 of those studies with a site in Lyon that also match the filters currently applied.

How many clinical trials are recruiting in Lyon?

12 of the 35 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 23 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lyon), 35 studies
PhaseStudiesRecruitingShare
Phase 319854.3%
Phase 27220%
Phase 1/24111.4%
Phase 2/3318.6%
Observational102.9%
Phase 4102.9%

Most active sponsors

Lead sponsors with the most studies (Lyon)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche3512
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.